Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2004-10-8
pubmed:abstractText
We report results of an immunoassay for Blastomyces dermatitidis antigenuria. Sensitivity was 92.9%, and specificity was 79.3%. Cross-reactions occurred in 96.3% of patients with histoplasmosis, 100% of patients with paracoccidioidomycosis, 70% of patients with penicilliosis marneffei, 2.9% of patients with cryptococcosis, and 1.1% of patients with aspergillosis. Reproducibility was 96.3%. These findings support a potential role for antigen testing in blastomycosis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-10452633, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-11149972, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-12089732, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-1562691, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-2868172, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-3941695, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-9195077, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-9276396, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-9313293, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-9316555, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-9375492, http://linkedlifedata.com/resource/pubmed/commentcorrection/15472368-9726727
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4873-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Antigen assay with the potential to aid in diagnosis of blastomycosis.
pubmed:affiliation
MiraVista Diagnostics/MiraBella Technologies, Indianapolis, Indiana 46241, USA. mdurkin@miravistalabs.com
pubmed:publicationType
Journal Article, Evaluation Studies